Giant Non-Functioning Pituitary Adenomas: Treatment Considerations

被引:0
|
作者
Solari, Domenico [1 ]
Cavallo, Luigi Maria [1 ]
Graziadio, Chiara [2 ]
Corvino, Sergio [1 ]
Bove, Ilaria [1 ]
Esposito, Felice [1 ]
Cappabianca, Paolo [1 ]
机构
[1] Univ Napoli Federico II, Div Neurosurg, Via Pansini 5, I-80131 Naples, Italy
[2] Univ Napoli Federico II, Div Endocrinol, Via Pansini 5, I-80131 Naples, Italy
关键词
pituitary adenomas; endoscopic endonasal surgery; skull base surgery; pituitary; hypothalamus; endocrinology; neurosurgery; giant tumors; ENDONASAL TRANSSPHENOIDAL APPROACH; CRANIAL BASE DEFECTS; SKULL BASE; SURGICAL-TREATMENT; SURGERY; RESECTION; RECONSTRUCTION; PREVALENCE; MANAGEMENT; VASOSPASM;
D O I
10.3390/brainsci12091256
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Giant pituitary adenomas are a subgroup of pituitary adenomas defined by a diameter greater than 4 cm, and they account for 5-14% of adenomas in surgical series. Because of their growth patterns and locations, often involving critical neurovascular structures, they represent a true surgical challenge, and gross total resection is difficult to achieve. There is no consensus on the optimal surgical strategy for giant pituitary adenomas, and, often, integrated multi-staged treatment strategies have been considered. Transcranial or transsphenoidal approaches, alone or combined, according to tumor and patient features are the two main routes. Each of these strategies has pros and cons. The conventional transcranial approach has for a long time been considered the first choice for the removal of giant pituitary adenomas. Currently, with endoscopic techniques, it is also possible to remove lesions that involve the intradural compartment and the adjacent neurovascular structures with the use of extended approaches. Our policy for the management of these lesions is to adopt the endoscopic endonasal approach as the first choice unless the tumor presents significant intracranial extension that results in it being outside the visibility and maneuverability of the endoscopic endonasal route. In these latter cases, we agree that the transcranial approach is more appropriate. However, accurate preoperative evaluation and refined treatment plans for each patient are mandatory to define a proper strategy in order to achieve the most effective long-term result.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Optimal management of non-functioning pituitary adenomas
    Greenman, Yona
    Stern, Naftali
    ENDOCRINE, 2015, 50 (01) : 51 - 55
  • [22] Management of patients with non-functioning pituitary adenomas
    Köbberling, J
    MEDIZINISCHE KLINIK, 2003, 98 (11) : 616 - 616
  • [23] Molecular alterations in non-functioning pituitary adenomas
    Taniguchi-Ponciano, Keiko
    Gomez-Apo, Erick
    Chavez-Macias, Laura
    Vargas, Guadalupe
    Espinosa-Cardenas, Etual
    Ramirez-Renteria, Claudia
    Ferreira-Hermosillo, Aldo
    Sosa, Ernesto
    Silva-Roman, Gloria
    Pena-Martinez, Eduardo
    Andonegui-Elguera, Sergio
    Vargas-Chavez, Sonia
    Santiago-Andres, Yorgui
    Peralta, Raul
    Marrero-Rodriguez, Daniel
    Mercado, Moises
    CANCER BIOMARKERS, 2020, 28 (02) : 193 - 199
  • [24] Malignant transformation in non-functioning pituitary adenomas (pituitary carcinoma)
    Lenders, Nele
    McCormack, Ann
    PITUITARY, 2018, 21 (02) : 217 - 229
  • [25] Malignant transformation in non-functioning pituitary adenomas (pituitary carcinoma)
    Nèle Lenders
    Ann McCormack
    Pituitary, 2018, 21 : 217 - 229
  • [26] Solid tumor size for prediction of recurrence in large and giant non-functioning pituitary adenomas
    Ko, Ching-Chung
    Chang, Chin-Hong
    Chen, Tai-Yuan
    Lim, Sher-Wei
    Wu, Te-Chang
    Chen, Jeon-Hor
    Kuo, Yu-Ting
    NEUROSURGICAL REVIEW, 2022, 45 (02) : 1401 - 1411
  • [27] Solid tumor size for prediction of recurrence in large and giant non-functioning pituitary adenomas
    Ching-Chung Ko
    Chin-Hong Chang
    Tai-Yuan Chen
    Sher-Wei Lim
    Te-Chang Wu
    Jeon-Hor Chen
    Yu‐Ting Kuo
    Neurosurgical Review, 2022, 45 : 1401 - 1411
  • [28] Diagnosis and management of prolactinomas and non-functioning pituitary adenomas
    Rogers, Angela
    Karavitaki, Niki
    Wass, John A. H.
    BMJ-BRITISH MEDICAL JOURNAL, 2014, 349
  • [29] Non-Functioning Pituitary Adenomas: A Single Center Experience
    Anagnostis, P.
    Adamidou, F.
    Polyzos, S. A.
    Efstathiadou, Z.
    Panagiotou, A.
    Kita, M.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2011, 119 (05) : 314 - 319
  • [30] Telomerase expression in clinically non-functioning pituitary adenomas
    Ogino, Liana Lumi
    Lamback, Elisa Baranski
    Guterres, Alexandro
    de Azeredo Lima, Carlos Henrique
    Henriques, Daniel Gomes
    Barbosa, Monique Alvares
    Silva, Debora Aparecida
    da Silva Camacho, Aline Helen
    Chimelli, Leila
    Kasuki, Leandro
    Gadelha, Monica R.
    ENDOCRINE, 2021, 72 (01) : 208 - 215